TMO
54
2
R
59
4
NEE
42
3
XRAY
31
2
GM
57
2
PHM
46
2
LMT
39
10
PFG
30
3
PX
53
-3
QRVO
18
2
EQIX
57
-2
CHRW
51
-2
LB
19
3
MCHP
36
3
VFC
53
-3
KR
46
-4
AON
28
2
PGR
49
4
ESS
47
3
STI
21
9
TMO
54
2
R
59
4
NEE
42
3
XRAY
31
2
GM
57
2
PHM
46
2
LMT
39
10
PFG
30
3
PX
53
-3
QRVO
18
2
EQIX
57
-2
CHRW
51
-2
LB
19
3
MCHP
36
3
VFC
53
-3
KR
46
-4
AON
28
2
PGR
49
4
ESS
47
3
STI
21
9
Financhill
Back

Ginkgo Bioworks Holdings 10K Form

Sell
45

DNA
Ginkgo Bioworks Holdings

Last Price:
$9.35
Seasonality Move:
-43.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DNA News And Ratings

See the #1 stock for the next 7 days that we like better than DNA

DNA Financial Statistics

Sales & Book Value

Annual Sales: $251.5M
Cash Flow: $-118.6M
Price / Cash Flow: 0
Annual Sales: $15.03
Price / Book: 0.68

Profitability

EPS (TTM): -12.99000
Net Income (TTM): $-651.2M
Gross Margin: $197.5M
Return on Equity: -65.54%
Return on Assets: -38.86%

Ginkgo Bioworks Holdings Earnings Forecast

Key Ginkgo Bioworks Holdings Financial Ratios

  • The Gross Profit Margin over the past 5 years for DNA is 78.52%.
  • The Selling, General & Administrative Expenses for DNA have been equal to 153.12% of Gross Profit Margin.
  • The Research & Development expenses have been 230.90% of Revenue.
  • The Interest Expense is -0.01% of Operating Income.
  • The Net Earning history of DNA is -355.08% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Ginkgo Bioworks Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Chemicals
Sector: Materials
Current Symbol: DNA
Website: ginkgobioworks.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.79
Quick Ratio: 5.59

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

DNA Technical Analysis vs Fundamental Analysis

Sell
45
Ginkgo Bioworks Holdings (DNA) is a Sell

Is Ginkgo Bioworks Holdings a Buy or a Sell?